Compounds > adenosine diphosphate
Page last updated: 2024-08-17

adenosine diphosphate and Degenerative Diseases, Central Nervous System

adenosine diphosphate has been researched along with Degenerative Diseases, Central Nervous System in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Bretonneau, C; Labarre, A; Livernoche, R; Maios, C; Parker, JA; Tossing, G1
Lai, MC; Liou, SS; Liu, IM; Liu, WY1
Abramov, AY; Arber, C; Bartolome, F; Carro, E; de Vicente, M; Gandhi, S; Houlden, H; Ludtmann, MHR; Preza, E; Wray, S1
Hoffmann, K; von Kügelgen, I1
Dolder, M; Schlattner, U; Speer, O; Wallimann, T; Walzel, B1

Reviews

1 review(s) available for adenosine diphosphate and Degenerative Diseases, Central Nervous System

ArticleYear
Pharmacology and structure of P2Y receptors.
    Neuropharmacology, 2016, Volume: 104

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Brain; Cardiovascular Diseases; Humans; Microglia; Neurodegenerative Diseases; Neurons; Platelet Aggregation; Purinergic P2Y Receptor Agonists; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y; Uridine Triphosphate

2016

Other Studies

4 other study(ies) available for adenosine diphosphate and Degenerative Diseases, Central Nervous System

ArticleYear
Genetic and pharmacological PARP inhibition reduces axonal degeneration in C. elegans models of ALS.
    Human molecular genetics, 2022, 09-29, Volume: 31, Issue:19

    Topics: Adenosine Diphosphate; Amyotrophic Lateral Sclerosis; Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; MAP Kinase Kinase Kinases; Neurodegenerative Diseases; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerase Inhibitors; Ribose

2022
A Bibenzyl Component Moscatilin Mitigates Glycation-Mediated Damages in an SH-SY5Y Cell Model of Neurodegenerative Diseases through AMPK Activation and RAGE/NF-
    Molecules (Basel, Switzerland), 2020, Oct-07, Volume: 25, Issue:19

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; AMP-Activated Protein Kinases; Benzyl Compounds; Blotting, Western; Cell Survival; DNA Fragmentation; Glutathione; Glycation End Products, Advanced; Humans; Lipid Peroxidation; Membrane Potential, Mitochondrial; Neurodegenerative Diseases; NF-kappa B; Oxidative Stress; Reactive Oxygen Species; Receptor for Advanced Glycation End Products

2020
Mutations in valosin-containing protein (VCP) decrease ADP/ATP translocation across the mitochondrial membrane and impair energy metabolism in human neurons.
    The Journal of biological chemistry, 2017, 05-26, Volume: 292, Issue:21

    Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Biological Transport, Active; Cell Cycle Proteins; Cell Line, Tumor; Humans; Induced Pluripotent Stem Cells; Mitochondrial ADP, ATP Translocases; Mitochondrial Membranes; Mutation; Neurodegenerative Diseases; Neurons; Proteostasis Deficiencies; Valosin Containing Protein

2017
Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation.
    The Journal of biological chemistry, 2003, May-16, Volume: 278, Issue:20

    Topics: Adenine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Calcium; Cell Survival; Chromatography, Thin Layer; Creatine; Creatine Kinase; Creatinine; Dose-Response Relationship, Drug; Guanidines; Ion Channels; Liver; Magnesium; Mice; Mice, Transgenic; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Models, Biological; Neurodegenerative Diseases; Oxygen; Oxygen Consumption; Phosphocreatine; Phosphorylation; Propionates; Protein Binding; Time Factors

2003